MedTrace Logo

Impact of Co Enzyme Q10 as Adjuvant Therapy to Letrozole on Spermiogram

NCT05847257 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 74

Last updated 2025-02-19

No results posted yet for this study

Summary

Worldwide infertility affects about 15 % of reproductive-age couples. In many cases, infertility can't be treated, new treatment options with promising value were involved in the recent clinical trials.

Conditions

  • Male Reproductive Problem
  • Infertility, Male

Interventions

DRUG

Letrozole tablets

letrozole 2.5mg twice weekly for 3 months

DIETARY_SUPPLEMENT

Coenzyme Q10 table

Coenzyme Q10 400 mg per day for 3 months

Sponsors & Collaborators

  • Al-Nahrain University

    collaborator OTHER

  • Al-Mustansiriyah University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-01
Primary Completion
2022-10-30
Completion
2022-10-30

Countries

  • Iraq

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05847257 on ClinicalTrials.gov